Proactiveinvestors United Kingdom Kintara Therapeutics https://www.proactiveinvestors.co.uk Proactiveinvestors United Kingdom Kintara Therapeutics RSS feed en Fri, 05 Mar 2021 10:34:38 +0000 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) Kintara Therapeutics appoints Dr Mario Lacouture to its scientific advisory board for cutaneous metastatic breast cancer https://www.proactiveinvestors.co.uk/companies/news/942867/kintara-therapeutics-appoints-dr-mario-lacouture-to-its-scientific-advisory-board-for-cutaneous-metastatic-breast-cancer-942867.html Wed, 03 Mar 2021 14:20:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/942867/kintara-therapeutics-appoints-dr-mario-lacouture-to-its-scientific-advisory-board-for-cutaneous-metastatic-breast-cancer-942867.html Kintara achieves 'major milestone' by enrolling last patient in Phase 2 trial to treat brain cancer https://www.proactiveinvestors.co.uk/companies/news/942192/kintara-achieves--major-milestone--by-enrolling-last-patient-in-phase-2-trial-to-treat-brain-cancer-942192.html Wed, 24 Feb 2021 13:27:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/942192/kintara-achieves--major-milestone--by-enrolling-last-patient-in-phase-2-trial-to-treat-brain-cancer-942192.html Kintara Therapeutics enrolls last patient in Phase 2 VAL-083 trial for recurrent glioblastoma multiforme https://www.proactiveinvestors.co.uk/companies/news/941589/kintara-therapeutics-enrolls-last-patient-in-phase-2-val-083-trial-for-recurrent-glioblastoma-multiforme-941589.html Wed, 17 Feb 2021 15:25:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/941589/kintara-therapeutics-enrolls-last-patient-in-phase-2-val-083-trial-for-recurrent-glioblastoma-multiforme-941589.html Kintara Therapeutics posts second-quarter results, noting it was an "important period of progress" https://www.proactiveinvestors.co.uk/companies/news/941218/kintara-therapeutics-posts-second-quarter-results-noting-itwas-an--important-period-of-progress--941218.html Fri, 12 Feb 2021 14:55:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/941218/kintara-therapeutics-posts-second-quarter-results-noting-itwas-an--important-period-of-progress--941218.html Kintara Therapeutics stock climbs after Aegis Capital analysts up price target to $7, repeat Buy rating https://www.proactiveinvestors.co.uk/companies/news/940350/kintara-therapeutics-stock-climbs-after-aegis-capital-analysts-up-price-target-to-7-repeat-buy-rating-940350.html Wed, 03 Feb 2021 19:22:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/940350/kintara-therapeutics-stock-climbs-after-aegis-capital-analysts-up-price-target-to-7-repeat-buy-rating-940350.html Kintara Therapeutics is developing innovative cancer therapies for rare, unmet medical needs https://www.proactiveinvestors.co.uk/companies/news/937995/kintara-therapeutics-is-developing-innovative-cancer-therapies-for-rare-unmet-medical-needs-937995.html Wed, 27 Jan 2021 11:45:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/937995/kintara-therapeutics-is-developing-innovative-cancer-therapies-for-rare-unmet-medical-needs-937995.html Kintara Therapeutics gets price target bump, repeat Buy rating from Maxim after glioblastoma trial kicks off https://www.proactiveinvestors.co.uk/companies/news/939520/kintara-therapeutics-gets-price-target-bump-repeat-buy-rating-from-maxim-after-glioblastoma-trial-kicks-off-939520.html Tue, 26 Jan 2021 17:27:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/939520/kintara-therapeutics-gets-price-target-bump-repeat-buy-rating-from-maxim-after-glioblastoma-trial-kicks-off-939520.html Dawson James issues Buy rating on Kintara Therapeutics as its VAL-083 selected for study to treat three major brain cancers https://www.proactiveinvestors.co.uk/companies/news/939187/dawson-james-issues-buy-rating-on-kintara-therapeutics-as-its-val-083-selected-for-study-to-treat-three-major-brain-cancers-939187.html Thu, 21 Jan 2021 20:43:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/939187/dawson-james-issues-buy-rating-on-kintara-therapeutics-as-its-val-083-selected-for-study-to-treat-three-major-brain-cancers-939187.html Kintara Therapeutics says enrollment has begun for innovative Phase 2/3 trial of VAL-083 for glioblastoma https://www.proactiveinvestors.co.uk/companies/news/938342/kintara-therapeutics-says-enrollment-has-begun-for-innovative-phase-23-trial-of-val-083-for-glioblastoma-938342.html Wed, 13 Jan 2021 14:53:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/938342/kintara-therapeutics-says-enrollment-has-begun-for-innovative-phase-23-trial-of-val-083-for-glioblastoma-938342.html Kintara Therapeutics and Kazia Therapeutics drugs to enter glioblastoma trial https://www.proactiveinvestors.co.uk/companies/news/937804/kintara-therapeutics-and-kazia-therapeutics-drugs-to-enter-glioblastoma-trial-937804.html Wed, 06 Jan 2021 18:53:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/937804/kintara-therapeutics-and-kazia-therapeutics-drugs-to-enter-glioblastoma-trial-937804.html Kintara Therapeutics and Kazia Therapeutics begin trial to treat deadly brain cancer, glioblastoma https://www.proactiveinvestors.co.uk/companies/news/937808/kintara-therapeutics-and-kazia-therapeutics-begin-trial-to-treat-deadly-brain-cancer-glioblastoma-937808.html Wed, 06 Jan 2021 18:30:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/937808/kintara-therapeutics-and-kazia-therapeutics-begin-trial-to-treat-deadly-brain-cancer-glioblastoma-937808.html Kintara Therapeutics boss outlines upcoming milestones for 2021 https://www.proactiveinvestors.co.uk/companies/news/936875/kintara-therapeutics-boss-outlines-upcoming-milestones-for-2021-936875.html Thu, 17 Dec 2020 16:21:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/936875/kintara-therapeutics-boss-outlines-upcoming-milestones-for-2021-936875.html Kintara expects to enroll first GBM patient in Phase 3 clinical trial by late 2020/early 2021 https://www.proactiveinvestors.co.uk/companies/news/936000/kintara-expects-to-enroll-first-gbm-patient-in-phase-3-clinical-trial-by-late-2020early-2021-936000.html Tue, 08 Dec 2020 15:25:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/936000/kintara-expects-to-enroll-first-gbm-patient-in-phase-3-clinical-trial-by-late-2020early-2021-936000.html DelMar Pharmaceuticals talks through Phase 2 data published in peer-reviewed journal 'Glioma' https://www.proactiveinvestors.co.uk/companies/news/912545/delmar-pharmaceuticals-talks-through-phase-2-data-published-in-peer-reviewed-journal--glioma--912545.html Mon, 10 Feb 2020 14:38:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/912545/delmar-pharmaceuticals-talks-through-phase-2-data-published-in-peer-reviewed-journal--glioma--912545.html DelMar Pharmaceuticals boosted on positive clinical trials update for VAL-083 https://www.proactiveinvestors.co.uk/companies/news/195195/delmar-pharmaceuticals-boosted-on-positive-clinical-trials-update-for-val-083-195195.html Tue, 17 Apr 2018 19:58:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/195195/delmar-pharmaceuticals-boosted-on-positive-clinical-trials-update-for-val-083-195195.html DelMar Pharmaceuticals' lead-product cancer treatment granted 'Fast Track' designation by US FDA https://www.proactiveinvestors.co.uk/companies/news/189272/delmar-pharmaceuticals-lead-product-cancer-treatment-granted-fast-track-designation-by-us-fda-189272.html Tue, 26 Dec 2017 13:47:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/189272/delmar-pharmaceuticals-lead-product-cancer-treatment-granted-fast-track-designation-by-us-fda-189272.html DelMar Pharmaceuticals races up on Nasdaq on brain cancer clinical trial news https://www.proactiveinvestors.co.uk/companies/news/179704/delmar-pharmaceuticals-races-up-on-nasdaq-on-brain-cancer-clinical-trial-news-179704.html Thu, 22 Jun 2017 17:26:00 +0100 https://www.proactiveinvestors.co.uk/companies/news/179704/delmar-pharmaceuticals-races-up-on-nasdaq-on-brain-cancer-clinical-trial-news-179704.html DelMar to collaborate with MD Anderson Cancer Center https://www.proactiveinvestors.co.uk/companies/news/121292/delmar-to-collaborate-with-md-anderson-cancer-center-121292.html Wed, 13 Jan 2016 13:40:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/121292/delmar-to-collaborate-with-md-anderson-cancer-center-121292.html Delmar reveals positive results from Phase 2 trial https://www.proactiveinvestors.co.uk/companies/news/119579/delmar-reveals-positive-results-from-phase-2-trial-119579.html Mon, 23 Nov 2015 13:45:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/119579/delmar-reveals-positive-results-from-phase-2-trial-119579.html Delmar Pharmaceuticals' VAL-083 shows promise as potential brain treatment https://www.proactiveinvestors.co.uk/companies/news/119050/delmar-pharmaceuticals-val-083-shows-promise-as-potential-brain-treatment-119050.html Wed, 11 Nov 2015 16:24:00 +0000 https://www.proactiveinvestors.co.uk/companies/news/119050/delmar-pharmaceuticals-val-083-shows-promise-as-potential-brain-treatment-119050.html